Amrit Ray, M.D., MBA, Chief Medical Officer, Janssen Pharmaceutical Companies, Johnson & Johnson
Bari Kowal, VP, Strategic Alliance and Development Lead, Pfizer
Coleen Glessner, Vice President, Head of Clinical Trial Process & Quality, Pfizer
Dalvir Gill, PhD, CEO, TransCelerate BioPharma Inc.
Deirdre BeVard, VP, Development Operations, Endo Pharmaceuticals
Eric Perakslis, former CIO and Chief Scientist (Informatics), U.S. FDA, Executive Director, Center for Biomedical Informatics, Harvard Medical School; Senior Advisor, Precision for Medicine
Brian Hagen, PhD, Leader in Decision and Risk Management, Managing Director, Decision Empowerment Institute
James Kime, Senior Director, Head of Global Outsourcing & Development, UCB BIOSCIENCES, INC.
Jeff S. Kasher, PhD. VP, Clinical Trial: Materials, Implementation and Transformation, Eli Lilly & Co.
Jim Young, VP Clinical Affairs and Program Management, Mallinckrodt Pharmaceuticals
Jodie Morrison, CEO, Tokai Pharmaceuticals
Joe Torre, EVP, Baseball Operations, MLB; Former Manager, New York Yankees; and Cancer Survivor
John Barry, Head, Vendor Management, Merck
Kenneth Getz, Internationally Recognized Expert on R&D, Director of Sponsored Research Programs, Associate Professor, Center for the Study of Drug Development, Tufts University School of Medicine
Adrian Otte, VP, Clinical Operations, Amgen
Roni Zeiger, MD, Former Chief Health Strategist, Google, Practicing Urgent Care Physician, and CEO, Smart Patients
Shirley L. Paddock, R.Ph. MBA, Chief Operations Officer, Chorus, Lilly Research Laboratories
Steven Whittaker, President and Independent Consultant, PharmaPM Consulting, LLC
Thomas Krohn, Advisor, Clinical Innovation, Eli Lilly & Co.

Partnerships in Clinical Trials 2014 Speaker Faculty

We are happy to announce the 2014 speaking faculty. We will continue to add additional
thought leaders and speakers as we finalize the agenda and address emerging trends.
  • Abbe Steel, Vice President, Patient & Physician Services, UBC
  • Adrian Otte, Vice President, Clinical Operations, Amgen
  • Alan Barge, CMO, Aslan Pharmaceuticals
  • Alan Wookey, Executive Director, LabCorp Clinical Trials
  • Alison Taber, Vice President, Global Data Management, Theorem Clinical Research
  • Amrit Ray, Chief Medical Officer, Janssen Pharmaceutical Companies of Johnson & Johnson
  • Anca Copasceu, Director, Clinical Operations, Biomarin Pharmaceuticals
  • Andreas Koester, MD, PhD, Vice President, Clinical Trial Innovation & External Alliances, Johnson & Johnson Pharmaceutical R & D
  • Andreas Schmidt, Manager, European external Collaborations Product Development Innovation Management, La Roche Ltd.
  • Andrew Rut, CEO, MyMeds&Me
  • Azizunissa Irumnaz, MD, Director, Clinical Trials Unit, Aga Khan University
  • Bari Kowal, Vice President, Pfizer
  • Barinder Marhok, R&D Practice Head, Cognizant Technology Solutions
  • Bernadette Donohue, Manager, Clinical Outsourcing, Mallinckrodt Pharmaceuticals
  • Beverly Harrison, Vice President, Clinical Development, Multiple Myeloma Research Consortium
  • Bob Albanese, VP of Operations, CSM
  • Bob Jones, Vice President, Analyst, Healthcare Services & Technology, Goldman Sachs
  • Bobby Galagram, Patient
  • Bonnie Brescia, Founding Principal, BBK Worldwide
  • Brian Arnold, Head of US Clinical Operations, Galderma R&D LLC
  • Brian Hagen, Managing Director, Decision Empowerment Institute
  • Brian Luce, CSO, Patient Centered Outcomes Research Institute
  • Bridget Reilly, Associate Director of Clinical Trial Partnerships, Bristol Myers Squibb
  • Christina Bodurow, Senior Director, External Sourcing, Eli Lilly & Co.
  • Christine Blazynski, CSO & SVP, Citeline, Inc.
  • Christine Rovinski, NA Scientific & Clinical Procurement, Swiftwater Site Lead PASTEUR & Global Lead Buyer, Sanofi—Aventis
  • Clara Heering, VP, Clinical Risk Management, ICON Clinical Research
  • Coleen Glessner, Vice President & Head of Clinical Trial Process & Quality, Pfizer
  • Colin Shannon, CEO, PRA
  • Conal Burgess, Vice President, Clinical Research Services, PAREXEL International
  • Constance Hopkins, Associate Director, Head of Site Contracts Management, UCB Biosciences
  • Crystal Wilmesherr, Sr. Clinical Outsourcing Specialist, Mallinckrodt Pharmaceuticals
  • Dalvir Gill, CEO, Transcelerate BioPharma Inc.
  • Dana Poff, Executive Vice President, Strategic Alliances, ICON Clinical Research
  • Dave Munneke, Clinical Program Manager, American Medical Systems
  • David Leventhal , Director, Clinical Innovation, Pfizer
  • David Jordan, Consultant, Global Pharmaceutical R&D, Abbvie
  • David Windley, Managing Director, Jeffries & Co.
  • Deirdre BeVard, Vice President, Clinical Operations , Endo Pharmaceuticals
  • Denise Calaprice-Whitty, PhD, Sr. Consultant , The Avoca Group
  • Deven V. Parmar, MD, FCP, Director, Clinical Development, Prolong Pharmaceuticals
  • Doug Plessinger, Vice President, Clinical and Medical Affairs, Argos Therapeutics
  • Doug Cowart, Executive Vice President, Development & Regulatory Affairs; Founder, Cardioxyl Pharmaceuticals
  • Douglas Tsao, U.S. Specialty Pharmaceuticals & CROs, Barclays Equity Research
  • Edwina Wyatt Knowles, Executive Director, Head of Global Clinical Pharmacology and Early Development Operations, Astellas Pharma Global Development
  • Eileen Daniel, Senior Director, Development Operations, Endo Pharmaceuticals
  • Elizabeth Mascherino, Associate Clinical Operations Director, Shire Pharmaceuticals
  • Elizabeth Shewell, Sr. Director of Outsourcing, Shire
  • Eric Morfin, Senior Director, Project Management, Allergan Biologics
  • Eric Coldwell, Managing Director, RW Baird
  • Frances Grote, Senior Director, Clinical Operations Vendor Oversight, Biogen Idec
  • Frederick Lewis, Vice President - Neurosciences Scientific Affairs, PRA
  • George Mulligan, PhD, Director Translational Medicine, Millennium Pharmaceuticals Inc.
  • Graeme Currie, PhD, Vice President, Clinical Project Management and Operations, Regeneron Pharmaceuticals Inc.
  • Graham Hughes , CMO , SAS
  • Gregg Dearhammer, President Strategic Resources, inVentiv Health Clinical
  • Hassan Movahhed, Senior Vice President, United Therapeutics
  • Hemant Patel, Director, Clinical Operations, ImmunoGen Inc.
  • J. Stephen Mikita, Patient Representative, CTTI
  • Jack Whelan, Cancer Warrior & Survivor
  • Jagath Wanninayake, President & CEO, Suvoda Software
  • James Kime, Senior Director, Head of Global Outsourcing & Development, UCB Biosciences
  • Jamie Macdonald, CEO, INC Research
  • Jeanne Ashton, Senior Vice President, Global Data Services, inVentiv Health Clinical
  • Jeff Kasher, VP, Clinical Development Operations, Eli Lilly & Co.
  • Jeff Wolf, UCSF
  • Jennifer Cutter, Director, Clinical Operations, Medpace Inc.
  • Jennifer Roberts, Head of Clinical and Program Operations, Tokai Pharmaceuticals
  • Jessica Lee, MS MPH, Senior Director, Clinical Development, Inovio Pharmaceuticals
  • Jeremy Gilbert, Vice President, Product and Strategy, PatientsLikeME
  • Jim Young, Vice President Clinical Affairs and Program Management, Mallinckrodt Pharmaceuticals
  • Jodie Morrison, CEO, Tokai Pharmaceuticals
  • Joan Chambers, COO, CenterWatch
  • Johann Proeve, Global Strategy and Development Advisor, Global Data Sciences and Analytics, Bayer Vital GmbH
  • John Burnett, Clinical Research Manager, Vistakon
  • John Barry, Head, Vendor Management, Merck
  • John Lamattina, Senior Partner, PureTech Ventures
  • John Lewis, Vice President of Public Affairs, ACRO
  • John Potthoff, President and CEO, Thereom Clinical Research
  • John Whitaker, Senior Vice President, Clinical Innovation, INC Research
  • Joris van Dam, Strategic Projects Leader, Novartis
  • Joseph Kim, Director, Clinical Operations , Shire Pharmaceuticals
  • Karrie Hilsinger, Director, Clinical Operations, Valeritas
  • Kathryn King, VP Golbal Clinical Operations, Takeda Pharmaceuticals International, Inc.
  • Kelly McKee, Associate Director, Clinical Research, Global Trial Optimization, Merck
  • Kenneth Getz, Director of Sponsored Programs, Tufts University School of Medicine
  • Kent Thoelke, Executive Vice President, Scientific & Medical Affairs, PRA
  • Lane Raspberry, Clinical Trial Participant
  • Lawrence Florin, Consulting Partnerships, Medidata Solutions Worldwide
  • Leslie Bihari, Jr. President, eClipse CRO
  • Lori A. Ball, MBA, COO, BioStorage Technologies
  • Mahtab Fatemi, Director of Regulatory Affairs, Holaira
  • Marc Penniston, Senior Vice President and General Manager, Clinical Analytics Theorem Clinical Research
  • Maria Koutsopoulo, Global Head, Regional Clinical Operations Merck Serono
  • Marisa Co, Vice President R&D and Global Procurement, BMS
  • Mark Weinstein, President and CEO, Bioclinica
  • Mary Rose, Vice President, Clinical Operations , Sangart
  • Matthew Eckman, Principal Financial Risk Manager, Genentech
  • Michael Luker, Senior Advisor, Clinical Development Innovation, Eli Lilly and Co.
  • Michael Martorelli, Director, Fairmount Partners
  • Milbhor D'Silva, US Head of Pharmacovigiliance, Astellas
  • Mitchell Katz, Executive Director, Purdue Pharma L.P.
  • Mohan R. Banglaore, PhD, MBA, Director, R&D Operations, Bristol-Myers Squibb
  • Murray Abramson, Vice President, Clinical Operations , Biogen Idec
  • Nancy Snowden, Founder and President, NCGS Incorporated
  • Patrecia Flynn Valone, Sr. Director Development Operations, Takeda Development Center, Asia / Takeda Shanghai Develpment Center
  • Patrice Hugo, Sr. Global Dir. Scientific Affairs, LabCorp Clinical Trials
  • Patricia Devitt, President ACT Oncology
  • Patrick Hughes, CCO, Clue Points
  • Paulo Moreira, VP Global Clinical Operations - External Innovation merck Serono
  • Peter Foote, Head, Clinical Operations and Data Assessment, XOMA (USA), LLC.
  • R. Stephen Porter, Founder and Chief Scientific Officer , VDDI Pharmaceuticals
  • Rafael Escando, Vice President, Clinical Operations, Labrys Biologics, Inc.
  • Rachel Garrido, Sr. Director, Early Phase Strategic Unit, PAREXEL International
  • Ratan Ratnesh, Director of Outsourcing, Otsuka
  • Rick O'Hara, Associate Director, Clinical Research, Endo Pharmaceuticals
  • Robert Wilson, Senior Vice President of Business Development, Actigraph
  • Roger Hunter, Vice President strategic Partnerships, Chiltern
  • Roni Zeiger, CEO SmartPatients
  • Shantal Feltham, President and CEO, Stiris Clinical Research
  • Sharon Hanlon, Director of Clinical Trial Partnerships, BMS
  • Sharon Moore, MD, EVP Global Medical and Regulatory Affairs, Chiltern
  • Shirley Paddock, COO, Chorus, Eli Lilly and Co.
  • Steve Miller, MD, SVP & Chief Medical Officer, Express Scripts
  • Steve Sweeney, VP, Clinical Development Operations, Annovation Biopharma
  • Steven Whittaker, President and Independent Consultant, PharmaPM Consulting LLC
  • Susan McHale, Executive Director, Global Project Delivery, AstraZeneca
  • Thomas Krohn, Director, Clinical Innovation, Eli Lilly & Co.
  • Todd Georgieff, Clinical Country Operations, Genentech
  • Tom Hawthorne, Associate Director, Bioanalytics, Celldex Therapeutics
  • Tomasz Sablinski, Founder & CEO, Transparency Life Science
  • William Smith, President, Principal Investigator, New Orleans Center for Clinical Research and Volunteer Research Group
  • Wolfgang Renz, Vice President, Business Model & Healthcare Innovation , Boehringer Ingelheim
  • Yanping Zheng, Medical Director , Mallinckrodt Pharmaceuticals
  • Zaher El-Assisi, President, eClinical Merge eClinical
*Track/Summit Chair
© 2013 IIR HOLDINGS, LTD. All Rights Reserved.